Investors / Oncology Ventures
Oncology Ventures
Venture capital
Oncology Ventures is an investment firm that backs commercially-validated start-ups working to transform cancer care. It focuses on healthcare data companies addressing problems across the U.S. oncology system, from early detection to patient navigation and AI-powered treatment optimization.
Invests inHealthcare & Biotech
In its own wordsoncologyhealthcare dataearly detectionpatient navigationaicancer care
Your fit with Oncology Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsOncology Ventures lists 9 checked portfolio companies on its own site and is named in 10 funding rounds. Its most frequent entry is Series A, 63% of the companies with a known first round. Its largest themes are Healthcare & Biotech (73%), Enterprise Software (9%) and AI & Machine Learning (9%). 67% of its companies are based in United States. It invests most often alongside Battery Ventures, Blue Venture Funds and Endurance28.
Counts come from funding rounds that name Oncology Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundOncology Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 13% |
| Series A | 63% |
| Series B | 25% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 5 | 0 |
| '26 | 5 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 19th | 9 companies |
| Recent activity | 89th | 6 rounds in 12 months |
| Early stage | 55th | 13% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 92th | 73% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Battery Ventures | 1 |
| Blue Venture Funds | 1 |
| Endurance28 | 1 |
| Epsilon Health Investors | 1 |
| F-Prime Capital | 1 |
| FCA Venture Partners | 1 |
| Frist Cressey Ventures | 1 |
| General Catalyst | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers9100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 73% | 15% |
| Enterprise Software | 9% | 8% |
| AI & Machine Learning | 9% | 18% |
| Consumer | 9% | 3% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Battery Ventures
Compare Oncology Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Oncology Ventures| Date | Company | Stage |
|---|---|---|
| 28 May 2026 | Series B | |
| 6 May 2026 | Seed | |
| 5 Mar 2026 | Series A | |
| 20 Jan 2026 | Round | |
| 13 Jan 2026 | Series A | |
| 19 Nov 2025 | Series A | |
| 6 Nov 2025 | Series B | |
| 4 Nov 2025 | Series A |
Round details for Oncology Ventures
Amounts, full round histories and every co-investor in Oncology Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
9 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Biomakers provides genomic testing and data solutions for cancer care and research. | Healthcare & Biotech | Jan 2026Round | Funding round | |
| Daymark Health provides in-home and virtual cancer care services to patients. | Healthcare & Biotech | Sept 2025Series A | Funding round | |
| Ignite Data provides technology for clinical trial data integration and transfer between research sites and sponsors. | Healthcare & Biotech | Aug 2025Series A · 2 rounds | Funding round | |
| Lumonus develops a connected platform for radiation oncology that automates routine work and integrates with existing systems | Healthcare & Biotech | Nov 2025Series B | Funding round | |
| Modicus Prime develops and provides enterprise software for managing artificial intelligence applications in the pharmaceutical industry | Healthcare & BiotechEnterprise Software | May 2026Seed | Funding round | |
| NexCure partners with health systems to build and operate outpatient treatment centers focusing on CAR-T and T-cell engagers. | Healthcare & Biotech | Mar 2026Series A | Funding round | |
| RISA develops an AI operating system for oncology to automate prior authorization, medication access, and workflows that delay patient care. | Healthcare & BiotechAI & Machine Learning | Jan 2026Series A | Funding round | |
| Triomics structures unstructured electronic health records into actionable datasets for cancer care | Healthcare & Biotech | May 2026Series B | Funding round | |
| Wellbeam Consumer Health produces and sells consumer wellness products, including supplements and skincare, under various brand names. | Healthcare & BiotechConsumer | Nov 2025Series A | Funding round |
About this data
site last read 12 Nov 2026- Site
- oncology.ventures
- Last read
- 12 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 14 Aug 2025
- Companies checked
- 9
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Oncology Ventures' profile as data
Pull Oncology Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/oncology.ventures
# also
GET /v1/firms/oncology.ventures/portfolio
GET /v1/firms/oncology.ventures/coinvestors
GET /v1/firms/oncology.ventures/news